Testosterone stearate
 | |
| Clinical data | |
|---|---|
| Other names | Testosterone octadecanoate; Testosterone 17β-stearate; Androst-4-en-17β-ol-3-one 17β-stearate |
| Routes of administration | Oral, intramuscular injection |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C37H62O3 |
| Molar mass | 554.900 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Testosterone stearate, also known as testosterone octadecanoate, testosterone 17β-stearate, and androst-4-en-17β-ol-3-one 17β-stearate, is an injected anabolic-androgenic steroid (AAS) and an androgen ester – specifically, the C17β stearate (octadecanoate) ester of testosterone – which was never marketed.[1][2] It is a prodrug of testosterone and, when administered via intramuscular injection, is associated with a long-lasting depot effect and extended duration of action.[1] Testosterone stearate may occur naturally in the body.[3]
It has been said that with longer-chain esters of testosterone like testosterone stearate, the duration of action may be so protracted that the magnitude of effect with typical doses may be too low to be appreciable.[1]
See also
References
- ^ a b c Vitamins and Hormones. Academic Press. 1 January 1944. pp. 384–. ISBN 978-0-08-086599-7.
{{cite book}}: ISBN / Date incompatibility (help) - ^ Josephy E, Radt F (1 December 2013). Elsevier's Encyclopaedia of Organic Chemistry: Series III: Carboisocyclic Condensed Compounds. Springer. pp. 3048–. ISBN 978-3-662-25863-7.
- ^ Oettel M, Schillinger E (6 December 2012). Estrogens and Antiestrogens I: Physiology and Mechanisms of Action of Estrogens and Antiestrogens. Springer Science & Business Media. pp. 236–. ISBN 978-3-642-58616-3.